Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data

603520 Zhejiang Starry Pharmaceutical

16.850
+0.610+3.76%
Extended Morning Session 09/27 11:29 CCT
High
16.900
Open
16.280
Turnover
89.70M
Low
16.280
Pre Close
16.240
Volume
53.81K
Market Cap
5.78B
P/E(TTM)
24.89
52wk High
48.215
Shares
342.91M
P/E(Static)
17.85
52wk Low
16.070
Float Cap
5.77B
Bid/Ask %
-43.62%
Historical High
69.643
Shs Float
342.29M
Volume Ratio
1.38
Historical Low
4.974
Dividend TTM
0.357
Div Yield TTM
--
P/B
3.06
Dividend LFY
2.12%
Div Yield LFY
--
Turnover Ratio
1.57%
Amplitude
3.82%
Avg Price
16.671
Lot Size
100
Float Cap
5.77B
Bid/Ask %
-43.62%
Historical High
69.643
Shs Float
342.29M
Volume Ratio
1.38
Historical Low
4.974
Dividend TTM
0.357
Limit Up
17.860
P/B
3.06
Dividend LFY
2.12%
Limit Down
14.620
Turnover Ratio
1.57%
Amplitude
3.82%
Avg Price
16.671
Lot Size
100
Ask
18.33Klots
Bid
33.56Klots
Price Forecast

No Data

News

Comment

Company Overview More
The company was founded in 1997, is a professional research and development, production and sales of X-CT Nonionic contrast agent series and quinolone series of raw materials and intermediates of high-tech enterprises, is the largest domestic contrast agent imitation drug products, the most complete variety of factories. The company is a high-tech enterprise specializing in R & D, production and sales of pharmaceutical raw materials. The company's main products are Nonionic iodine contrast agent series drugs, and the business of the company and its subsidiaries has covered the production and sales of iohexol, iodoparanol, iodoxalol intermediates, APIs and preparations in iodine contrast agent series products. At the same time, the company deeply ploughed levofloxacin series products for many years, production and sales of levofloxacin raw materials and intermediates. The company is a high-tech enterprise, has undertaken a number of national and provincial research projects, and successfully completed the acceptance of the results, and obtained a number of certificates. The "Nonionic X-CT contrast agent API-iohexol" project undertaken by the company has won the "National Torch Plan Project Certificate" issued by the Torch High-tech Industry Development Center of the Ministry of Science and Technology of the people's Republic of China. Iohexol is also rated as "Zhejiang High-tech products" by the Department of Science and Technology of Zhejiang Province and "Taizhou famous Brand products" by Taizhou famous Brand Product Identification Committee. The project "synthetic process Development and industrialization of High Purity Nonionic X-CT contrast Agent-iohexol" was awarded as "Zhejiang Science and Technology second Prize" and "Taizhou Science and Technology Progress first Prize" by Zhejiang Provincial people's Government and Taizhou Municipal people's Government respectively.
CEO: --
Market: --
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...